NodThera ^Companies

NodThera is a biotechnology company based in Cambridge, UK, that focuses on the discovery and development of new treatments for chronic inflammatory and neuroinflammatory diseases. Their main goal is to target inflammation at its source by developing inhibitors of the NLRP3 inflammasome, which is a key driver of inflammation in the body and brain. NodThera is a leader in the NLRP3 inflammasome space, with best-in-class molecules and a wealth of pre-clinical and clinical data. Their innovative approach has the potential to make a positive and meaningful difference in the lives of patients suffering from obesity, cardiometabolic, and neurodegenerative diseases.